Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(1), P. 188 - 188
Published: Jan. 15, 2024
The
translocator
protein
(TSPO)
has
been
proven
to
have
great
potential
as
a
target
for
the
positron
emission
tomography
(PET)
imaging
of
glioblastoma.
However,
there
is
an
ongoing
debate
about
various
sources
TSPO
PET
signal.
This
work
investigates
impact
inoculation-driven
immune
response
on
signal
in
experimental
orthotopic
Cell,
Journal Year:
2023,
Volume and Issue:
186(17), P. 3706 - 3725.e29
Published: Aug. 1, 2023
The
bone
marrow
in
the
skull
is
important
for
shaping
immune
responses
brain
and
meninges,
but
its
molecular
makeup
among
bones
relevance
human
diseases
remain
unclear.
Here,
we
show
that
mouse
has
most
distinct
transcriptomic
profile
compared
with
other
states
of
health
injury,
characterized
by
a
late-stage
neutrophil
phenotype.
In
humans,
proteome
analysis
reveals
distinct,
differentially
expressed
neutrophil-related
pathways
unique
synaptic
protein
signature.
3D
imaging
demonstrates
structural
cellular
details
skull-meninges
connections
(SMCs)
veins.
Last,
using
translocator
positron
emission
tomography
(TSPO-PET)
imaging,
reflects
inflammatory
disease-specific
spatial
distribution
patients
various
neurological
disorders.
anatomical
functional
potential
as
site
diagnosing,
monitoring,
treating
diseases.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 7, 2024
Summary
Tau-PET
receives
growing
interest
as
an
imaging
biomarker
for
the
4-repeat
tauopathy
progressive
supranuclear
palsy
(PSP).
However,
translation
of
in
vitro
4R-tau
binding
to
vivo
tau-PET
signals
is
still
unclear.
Therefore,
we
conducted
a
longitudinal
[
18
F]PI-2620
PET/MRI
study
4-repeat-tau
mouse
model
(PS19)
and
found
elevated
PET
signal
presence
high
neuronal
tau.
Cell
sorting
after
radiotracer
injection
revealed
higher
tracer
uptake
single
neurons
compared
astrocytes
PS19
mice.
Regional
during
lifetime
correlated
with
abundance
fibrillary
tau
subsequent
autopsy
samples
PSP
patients
disease
controls.
In
autoradiography,
tau-positive
oligodendrocytes
AT8
density
but
not
were
driver
autoradiography
PSP.
summary,
oligodendroglial
constitutes
dominant
source
4-repeat-tauopathies,
yielding
capacity
translate
signal.
Genomic psychiatry :,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 6
Published: April 29, 2025
Abnormal
α-synuclein
aggregation
is
a
pathological
hallmark
of
Parkinson's
disease,
multiple
system
atrophy,
and
dementia
with
Lewy
bodies.
A
suitable
radiotracer
that
can
noninvasively
map
synucleinopathies
through
positron
emission
tomography
(PET)
will
lead
to
breakthroughs
in
early
diagnosis,
monitoring
disease
progression,
evaluating
treatment
responses.
However,
the
development
PET
tracers
for
lagging
due
several
challenges.
In
this
perspective,
we
provide
brief
review
advancements
targeting
summarize
recent
clinical
studies
aimed
at
mapping
neurodegenerative
patients
using
these
tracers.
Acta Neuropathologica,
Journal Year:
2024,
Volume and Issue:
148(1)
Published: Nov. 24, 2024
Abstract
Tau
PET
has
attracted
increasing
interest
as
an
imaging
biomarker
for
4-repeat
(4R)-tauopathy
progressive
supranuclear
palsy
(PSP).
However,
the
translation
of
in
vitro
4R-tau
binding
to
vivo
tau
signals
is
still
unclear.
Therefore,
we
performed
a
translational
study
using
broad
spectrum
advanced
methodologies
investigate
sources
[
18
F]PI-2620
individuals
with
4R-tauopathies,
including
pilot
autopsy
patients.
First,
conducted
longitudinal
PET/MRI
4-repeat-tau
mouse
model
(PS19)
and
detected
elevated
presence
high
levels
neuronal
tau.
An
innovative
approach
involving
cell
sorting
after
radiotracer
injection
revealed
higher
tracer
uptake
single
neurons
than
astrocytes
PS19
mice.
Regional
during
lifetime
correlated
abundance
fibrillary
autoradiography
signal
intensity
PSP
patients
disease
controls
who
underwent
2–63
months
PET.
In
autoradiography,
tau-positive
oligodendrocytes
AT8
density,
but
not
astrocytes,
were
drivers
PSP.
The
at
boundary
gray
white
matter
facilitated
identification
optimized
frontal
lobe
target
region
detect
burden
summary,
oligodendroglial
constitutes
dominant
source
4-repeat-tauopathies,
translating
signal.
Theranostics,
Journal Year:
2024,
Volume and Issue:
14(16), P. 6319 - 6336
Published: Jan. 1, 2024
Triggering
receptor
expressed
on
myeloid
cells
2
(TREM2)
plays
an
essential
role
in
microglia
activation
and
is
being
investigated
as
a
potential
therapeutic
target
for
modulation
of
several
neurological
diseases.
In
this
study,
we
present
the
development
preclinical
evaluation
Neuro-Oncology Advances,
Journal Year:
2024,
Volume and Issue:
6(1)
Published: Jan. 1, 2024
Abstract
Background
Nonauditory
symptoms
can
be
a
prominent
feature
in
patients
with
sporadic
vestibular
schwannoma
(VS),
but
the
cause
of
these
is
unknown.
Inflammation
hypothesized
to
play
key
role
growth
and
symptomatic
presentation
VS,
this
study,
we
investigated
through
translocator
protein
(TSPO)
positron
emission
tomography
(PET)
whether
inflammation
occurred
within
“normal
appearing”
brain
such
its
association
tumor
growth.
Methods
Dynamic
PET
datasets
from
15
VS
(8
static
7
growing)
who
had
been
previously
imaged
using
TSPO
tracer
[11C](R)-PK11195
were
included.
Parametric
images
binding
potential
(BPND)
distribution
volume
ratio
(DVR)
derived
compared
across
groups
both
contralateral
ipsilateral
gray
(GM)
white
matter
(WM)
regions.
Voxel-wise
cluster
analysis
was
additionally
performed
identify
anatomical
regions
increased
binding.
Results
Compared
tumors,
growing
demonstrated
significantly
higher
cortical
(GM,
1.070
vs.
1.031,
P
=
.03)
whole
(GM
&
WM,
1.045
1.006,
DVR
values.
The
voxel-wise
supported
region-based
revealed
clusters
high
precentral,
postcentral,
prefrontal
cortex
VS.
Conclusions
We
present
first
vivo
evidence
expression
brains
These
results
provide
mechanistic
insight
into
development
nonauditory
highlight
need
for
further
studies
interrogating
neuroinflammation
driving
symptomatology.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 24, 2024
Abstract
Local
therapy
strategies
still
provide
only
limited
success
in
the
treatment
of
glioblastoma,
most
frequent
primary
brain
tumor
adults,
indicating
global
involvement
this
fatal
disease.
To
study
impact
neuroinflammation
distant
site
on
clinical
course
patients
with
we
performed
translocator
protein
(TSPO)-PET
newly
diagnosed
glioma
WHO
2
and
healthy
controls
compared
signals
non-lesion
(i.e.
contralateral)
hemisphere.
Back-translation
syngeneic
glioblastoma
mice
was
used
to
characterize
PET
alterations
a
cellular
level.
Ultimately,
multiplex
gene
expression
analyses
served
profile
immune
cells
remote
brain.
Our
revealed
elevated
TSPO-PET
contralateral
hemispheres
controls.
Contralateral
TSPO
associated
persisting
epilepsy
short
survival
independent
phenotype.
pinpointed
myeloid
as
source
signal
increases
complex
signature
comprised
joint
cell
activation
immunosuppression
regions.
In
brief,
within
hemisphere
is
poor
outcome
glioblastoma.
serves
detect
who
may
benefit
from
immunomodulatory
strategies.
Clinical Cancer Research,
Journal Year:
2024,
Volume and Issue:
30(20), P. 4618 - 4634
Published: Aug. 16, 2024
Current
therapy
strategies
still
provide
only
limited
success
in
the
treatment
of
glioblastoma,
most
frequent
primary
brain
tumor
adults.
In
addition
to
characterization
microenvironment,
global
changes
patients
with
glioblastoma
have
been
described.
However,
impact
and
molecular
signature
neuroinflammation
distant
site
not
yet
thoroughly
elucidated.